Changes in antibiotic prophylaxis prescribing and infective endocarditis admissions in England and Scotland following changes in national guidance: a quasi-experimental longitudinal study

Background Use of antibiotic prophylaxis (AP) prior to invasive dental procedures (IDPs) to prevent infective endocarditis (IE) fell dramatically in the UK when the National Institute for Health and Care Excellence (NICE) recommended its cessation in 2008. However, guidance implementation by dentists, general medical practitioners (GPs) and others differed in England and Scotland, particularly after 2018 when the Scottish Dental Clinical Effectiveness Programme advised Scottish dentists to consider AP for high-risk individuals. We compared the effects of this differing guidance on AP prescribing and IE-admissions. Methods A quasi-experimental (natural) longitudinal-study design was used to compare aggregated national AP prescribing (2002–2025) and IE-admissions data (1998–2025) for England and Scotland. Interrupted time series and difference-in-differences analyses were used to evaluate changes. Findings AP prescribing fell 93% in England after the 2008 NICE guidelines and remained low (2567 [95% CI 2433–2701] prescriptions/million/annum before 2008 vs 185 [95% CI 165–204] prescriptions/million/annum after 2021/2, p < 0.0001), while IE-admissions increased by 112% (26 [95% CI 25–27] admissions/million/annum before 2008 vs 55 [95% CI 54–56]/million/annum after 2021/2, p < 0.0001). In Scotland, AP prescribing fell less, because GP prescribing replaced some dental prescribing, then rose again after 2018 and finished 2.86 times higher than in England (1884 [95% CI 1816–1952] prescriptions/million before 2008 vs 528 [95% CI 350–705] prescriptions/million after 2021/2). Correspondingly, Scottish IE-admissions rose less (24 [95% CI 23–25] admissions/million before 2008 vs 34 [95% CI 32–37] admissions/million after 2021/2, p < 0.0001) than in England, and English IE-admissions/million ended 61% higher than in Scotland (p < 0.0001). Interpretation Although our data do not establish causality, they suggest that cessation of AP may be followed by a significant increase in IE-admissions compared with policies recommending AP for high-risk individuals. Funding None.

Authors

Institutions

Publication Details

Journal
The Lancet Regional Health - Europe
Published
2026-11-07
DOI
https://doi.org/10.1016/j.lanepe.2026.101923
Primary Topic
Infective Endocarditis Diagnosis and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Changes in antibiotic prophylaxis prescribing and infective endocarditis admissions in England and Scotland following changes in national guidance: a quasi-experimental longitudinal study

Mark Dayer, Peter B. Lockhart, Larry M. Baddour, Bernard Prendergast et al.
2 links
The Lancet Regional Health - Europe
Infective Endocarditis Diagnosis and Management
article

Changes in antibiotic prophylaxis prescribing and infective endocarditis admissions in England and Scotland following changes in national guidance: a quasi-experimental longitudinal study

Mark Dayer, Peter B. Lockhart, Larry M. Baddour, Bernard Prendergast, Martin H. Thornhill
article en

Abstract

Background Use of antibiotic prophylaxis (AP) prior to invasive dental procedures (IDPs) to prevent infective endocarditis (IE) fell dramatically in the UK when the National Institute for Health and Care Excellence (NICE) recommended its cessation in 2008. However, guidance implementation by dentists, general medical practitioners (GPs) and others differed in England and Scotland, particularly after 2018 when the Scottish Dental Clinical Effectiveness Programme advised Scottish dentists to consider AP for high-risk individuals. We compared the effects of this differing guidance on AP prescribing and IE-admissions. Methods A quasi-experimental (natural) longitudinal-study design was used to compare aggregated national AP prescribing (2002–2025) and IE-admissions data (1998–2025) for England and Scotland. Interrupted time series and difference-in-differences analyses were used to evaluate changes. Findings AP prescribing fell 93% in England after the 2008 NICE guidelines and remained low (2567 [95% CI 2433–2701] prescriptions/million/annum before 2008 vs 185 [95% CI 165–204] prescriptions/million/annum after 2021/2, p < 0.0001), while IE-admissions increased by 112% (26 [95% CI 25–27] admissions/million/annum before 2008 vs 55 [95% CI 54–56]/million/annum after 2021/2, p < 0.0001). In Scotland, AP prescribing fell less, because GP prescribing replaced some dental prescribing, then rose again after 2018 and finished 2.86 times higher than in England (1884 [95% CI 1816–1952] prescriptions/million before 2008 vs 528 [95% CI 350–705] prescriptions/million after 2021/2). Correspondingly, Scottish IE-admissions rose less (24 [95% CI 23–25] admissions/million before 2008 vs 34 [95% CI 32–37] admissions/million after 2021/2, p < 0.0001) than in England, and English IE-admissions/million ended 61% higher than in Scotland (p < 0.0001). Interpretation Although our data do not establish causality, they suggest that cessation of AP may be followed by a significant increase in IE-admissions compared with policies recommending AP for high-risk individuals. Funding None.

The Lancet Regional Health - EuropeVol. 72
Mayo Clinic (US), Carolinas Medical Center (US), Cleveland Clinic London (GB), Wake Forest University (US), University of Plymouth (GB), University of Sheffield (GB)
Good health and well-being
Openalex Percentile: Top 13%
Infective Endocarditis Diagnosis and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon